TETRANEURON
A new path for Alzheimer's disease
Spain
18 employees
Total: $8.50M
Biotechnology, Pharmaceutical
General Information
Spain
BounceWatch is an independent company data service, not affiliated with TETRANEURON . To contact TETRANEURON , visit tetraneuron.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does TETRANEURON compare?
A PDF of TETRANEURON and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting TETRANEURON soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is TETRANEURON on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
Spain Market
Biotechnology
About TETRANEURON
Business keywords: Drug discovery, Gene therapy, Alzheimer's disease, Neurodegenerative disease, Biomarker development, Healthcare innovation, Medical research, Neuroscience, Start-up, Investment opportunities
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Funding Round | €5.00M | - |
|
27 Dec 2022 |
| Debt Financing | €1.00M | 2 |
|
27 Dec 2021 |
| Funding Round | €2.50M | - |
|
29 Jun 2021 |
TETRANEURON Alternatives & Competitors
View All Alternatives
Therapeutic Solutions for Neurodegeneration
A Novel Approach to Neuroprotection
Stopping the wave of neurodegeneration at its source
FAQ About TETRANEURON
Source: BounceWatch company record for TETRANEURON , https://bouncewatch.com/company/tetraneuron, updated 24 October 2024. When citing, please name BounceWatch and link this page.
